Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -3.21
- Piotroski Score 2.00
- Grade Buy
- Symbol (OBIO)
- Company Orchestra BioMed Holdings, Inc.
- Price $4.88
- Changes Percentage (-0.81%)
- Change -$0.04
- Day Low $4.70
- Day High $5.01
- Year High $11.69
Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/11/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.46
- Trailing P/E Ratio -5.47
- Forward P/E Ratio -5.47
- P/E Growth -5.47
- Net Income $-49,120,000
Income Statement
Quarterly
Annual
Latest News of OBIO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Microbiologists discover "impossible" Pac-Man bacteria
A groundbreaking bacterium, Candidatus Uabimicrobium helgolandensis, displays unique abilities like engulfing other cells, challenging previous beliefs. This discovery sheds light on the evolution of ...
By Newsweek | 2 weeks ago -
How Can Probiotics Help Save Coral Reefs From The Ravage Of Disease?
Researchers are exploring the use of probiotics to help coral microbiomes combat stony coral tissue loss disease. Valeria Pizarro, a biologist, is leading a project to develop probiotic treatments for...
By Forbes | 1 month ago -
Astrobiologist Nathalie Cabrol: 'I believe Mars still has some big surprises for us'
Nathalie Cabrol, director of the Carl Sagan Center, discusses life in our solar system, Venus's lessons on global heating, and her view on Elon Musk. She emphasizes searching for universal life marker...
By The Guardian | 1 month ago